Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Radiology

• Publication date

  2016-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/RADIOL.2016152244PMID 27243267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Risk Factors Associated with Smaller Brain Volumes in Regions Identified as Early Predictors of Cognitive Decline.

  2016cited by this paper
• Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI

  2016cited by this paper
• Blood-brain barrier breakdown in the aging human hippocampus.

  2015cited by this paper
• Blood-brain barrier impairment in dementia: current and future in vivo assessments.

  2015cited by this paper
• Accurate Determination of Blood–Brain Barrier Permeability Using Dynamic Contrast-Enhanced T1-Weighted MRI: A Simulation and in vivo Study on Healthy Subjects and Multiple Sclerosis Patients

  2014cited by this paper
• Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review

  2013cited by this paper
• Blood–Brain Barrier Permeability and Long-Term Clinical and Imaging Outcomes in Cerebral Small Vessel Disease

  2013cited by this paper
• Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

  2013cited by this paper
• The pathobiology of vascular dementia.

  2013cited by this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment

  2011cited by this paper
• Development and clinical applications of the time intensity curve shape analysis in dynamic contrast enhanced MRI: a pixel-by-pixel approach

  2011cited by this paper
• O1‐07‐04: Blood‐brain barrier p‐glycoprotein function in Alzheimer's disease

  2011cited by this paper
• Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping

  2011cited by this paper
• Dual‐temporal resolution dynamic contrast‐enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions

  2011cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population.

  2010cited by this paper
• Vessel growth and function: depiction with contrast-enhanced MR imaging.

  2009cited by this paper
• Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

  2009cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Neurovascular unit dysfunction: A vascular component of Alzheimer disease?

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• Vascular volume and blood‐brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls

  2006cited by this paper
• Astrocyte–endothelial interactions at the blood–brain barrier

  2006cited by this paper
• Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

  2003cited by this paper
• Increased Blood-Brain Barrier Permeability in White Matter Lesions of Binswanger’s Disease Evaluated by Contrast-Enhanced MRI

  2002cited by this paper
• Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors

  2000cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Strategies for blood-brain barrier rejuvenation and repair.

  2026cites this paper
• Clearance of amyloid plaque via focused ultrasonication in a mouse model of Alzheimer's disease

  2026cites this paper
• Gadolinium- and water-based blood-brain barrier dysfunction measures in patients with sporadic small vessel disease

  2026cites this paper
• Inflammation-Associated Mechanisms of Blood–Brain Barrier Disruption and Depression Pathogenesis in People with and Without HIV

  2026cites this paper
• Subtle blood-brain barrier leakage quantification using DCE-MRI in subjective and mild cognitive impairment: A pilot sub-study of the Cognitive Ageing, Nutrition & Neurogenesis (CANN) trial

  2026cites this paper
• Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice

  2026cites this paper
• Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology

  2026cites this paper
• Mutations associated with Alzheimer's disease and aged serum synergistically elicit blood-brain barrier dysfunction in a tissue-engineered model.

  2026cites this paper
• The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential

  2026cites this paper
• Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities

  2025cites this paper
• Assessing blood-brain barrier (BBB) integrity in an Alzheimer’s disease mouse model: is the BBB globally or locally disrupted?

  2025cites this paper
• Exercise-mediated cerebrovascular repair in Alzheimer's disease: from pathophysiology to therapeutic precision

  2025cites this paper
• Extracellular vesicles contribute to the beneficial effects of exercise training in APP/PS1 mice

  2025cites this paper
• Hypercholesterolemia, oxidative stress, and low-grade inflammation: a potentially dangerous scenario to blood–brain barrier

  2025cites this paper
• Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina

  2025cites this paper
• Restoring brain barriers: an innovative approach for treating neurological disorders

  2025cites this paper
• Blood–brain barrier permeability changes in dogs with suspected canine cognitive dysfunction using magnetic resonance imaging subtraction enhancement analysis

  2025cites this paper
• The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease

  2025cites this paper
• Gadolinium-Based Imaging and the Study of Neurofluid Dynamics.

  2025cites this paper
• Hyperintensity of the left piriform cortex and amygdala on T2-weighted FLAIR images in patients with probable Alzheimer’s disease correlates with cerebral cortical atrophy

  2025cites this paper
• Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

  2025cites this paper
• Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD mice

  2025cites this paper
• Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina

  2025cites this paper
• MR Imaging Indices for Brain Interstitial Fluid Dynamics and the Effects of Orexin Antagonists on Sleep

  2025cites this paper
• Signal Modeling and Neuroimaging Applications of Perfusion MRI With Contrast Agent: Part 2 Dynamic Contrast-Enhanced Method

  2025cites this paper
• The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

  2025cites this paper
• Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer’s disease and candidate genetic biomarkers for treatment stratification

  2025cites this paper
• Polyphenols Bioactive Metabolites, and Their Anti-Biofilm and Neuroprotective Potential

  2025cites this paper
• From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer’s Disease

  2025cites this paper
• Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions

  2025cites this paper
• The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?

  2025cites this paper
• New Research on Biomarkers in Alzheimer's Continuum.

  2025cites this paper
• Exploring the Link Between Periodontitis and Alzheimer’s Disease—Could a Nanoparticulate Vaccine Break It?

  2025cites this paper
• Aged human serum induces vascular changes in an isogenic co-culture venule model

  2025cites this paper
• EHD4 and ASAP2 are critical negative regulators of the claudin-5-based endothelial barrier.

  2025cites this paper
• Decoding Blood-Brain Barrier Dysfunction in Alzheimer's Disease: Innovations and Challenges in Multimodal MRI and PET Imaging Biomarkers.

  2025cites this paper
• Blood-brain barrier water exchange in relation to amyloid, cognition and cerebrovascular burden

  2025cites this paper
• Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury

  2025cites this paper
• Gadolinium based contrast agent induced electrical conductivity heterogeneity analysis in the brain of Alzheimer’s disease

  2025cites this paper
• Brain Ischemia in Alzheimer’s Disease May Partly Counteract the Disruption of the Blood–Brain Barrier

  2025cites this paper
• Altered Clearance in Alzheimer's Disease and Cerebral Amyloid Angiopathy.

  2025cites this paper
• Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays.

  2025cites this paper
• Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.

  2025cites this paper
• MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection

  2025cites this paper
• Biomarkers of blood–brain barrier and neurovascular unit integrity in human cognitive impairment and dementia

  2025cites this paper
• Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls.

  2025cites this paper
• Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

  2025cites this paper
• Compartment-specific analysis reveals disrupted astrocytic calcium transients in Alzheimer’s mice

  2025cites this paper
• Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups

  2025cites this paper
• The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

  2025cites this paper
• Integrated machine learning identifies biomarkers for bilirubin-induced Alzheimer’s disease-like lesions in neonates and adults

  2025cites this paper
• Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review

  2025cites this paper
• The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

  2025cites this paper
• Quantitative PET imaging and modeling of molecular blood-brain barrier permeability

  2025cites this paper
• Decreased water exchange rate across the blood–brain barrier throughout the Alzheimer's disease continuum: Evidence from Chinese data

  2025cites this paper
• ST-SRPerf: Continuous spatiotemporal representation for perfusion MRI super-resolution through neural ODE and implicit neural representation

  2025cites this paper
• DCE-MRI reveals spatial pattern in heterogeneous blood-brain barrier leakage within white matter in cerebral small vessel disease

  2025cites this paper
• The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease

  2025cites this paper
• Repeatability of diffusion‐weighted arterial spin labeling MRI for mapping blood–brain barrier water exchange rate at different postlabel delays

  2025cites this paper
• Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis

  2024cites this paper
• Measurement of blood–brain barrier water exchange rate using diffusion‐prepared and multi‐echo arterial spin labelling: Comparison of quantitative values and age dependence

  2024cites this paper
• Unveiling the hidden connection: the blood-brain barrier’s role in epilepsy

  2024cites this paper
• Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes

  2024cites this paper
• The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis.

  2024cites this paper
• Biorobotic Drug Delivery for Biomedical Applications

  2024cites this paper
• Dysregulation of Porphyromonas gingivalis Agmatine Deiminase Expression in Alzheimer's Disease.

  2024cites this paper
• Imaging of enlarged perivascular spaces in Alzheimer’s disease with MRI techniques

  2024cites this paper
• No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer’s disease progression: a longitudinal study

  2024cites this paper
• NX210c drug candidate peptide strengthens mouse and human blood-brain barriers

  2024cites this paper
• Blood–Brain Barrier Permeability Is Associated With Cognitive Functioning in Normal Aging and Neurodegenerative Diseases

  2024cites this paper
• Platycodon grandiflorum root extract inhibits Aβ deposition by breaking the vicious circle linking oxidative stress and neuroinflammation in Alzheimer's disease.

  2024cites this paper
• Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

  2024cites this paper
• Blood–brain barrier integrity is linked to cognitive function, but not to cerebral arterial pulsatility, among elderly

  2024cites this paper
• Unraveling neurovascular mysteries: the role of endothelial glycocalyx dysfunction in Alzheimer’s disease pathogenesis

  2024cites this paper
• Quantitative PET imaging and modeling of molecular blood-brain barrier permeability

  2024cites this paper
• An easy-to-perform method for microvessel isolation and primary brain endothelial cell culture to study Alzheimer's disease

  2024cites this paper
• Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics

  2024cites this paper
• Imaging the cerebral vasculature at different scales: translational tools to investigate the neurovascular interfaces.

  2024cites this paper
• The Blood-Brain Barrier: Composition, Properties, and Roles in Brain Health.

  2024cites this paper
• The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases

  2024cites this paper
• Evidence of Pericyte Damage in a Cognitively Normal Cohort

  2024cites this paper
• Mechanism of Salvia miltiorrhiza Bunge extract to alleviate Chronic Sleep Deprivation-Induced cognitive dysfunction in rats.

  2024cites this paper
• Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: enhancing blood-brain barrier integrity and capillarization in the aged mouse brain

  2024cites this paper
• Alzheimer's Disease Pathophysiology in the Retina.

  2024cites this paper
• Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood

  2024cites this paper
• Blood-brain barrier biomarkers.

  2024cites this paper
• Developmental priming of early cerebrovascular ageing: Implications across a lifetime

  2024cites this paper
• [18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET imaging repurposed for quantitative estimation of blood-brain barrier permeability in a rat model of Alzheimer's disease.

  2024cites this paper
• Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?

  2024cites this paper
• Feasibility of measuring blood‐brain barrier permeability using ultra‐short echo time radial magnetic resonance imaging

  2024cites this paper
• Oligomeric Tau-induced Oxidative Damage and Functional Alterations in Cerebral Endothelial Cells: Role of RhoA/ROCK Signaling Pathway.

  2024cites this paper
• Associations between regional blood-brain barrier permeability, aging, and Alzheimer’s disease biomarkers in cognitively normal older adults

  2024cites this paper
• Evidence for interictal blood–brain barrier dysfunction in people with epilepsy

  2024cites this paper
• Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models

  2024cites this paper
• Clinical magnetic resonance imaging evaluation of glymphatic function

  2024cites this paper
• Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?

  2024cites this paper
• Cellular junction dynamics and Alzheimer’s disease: a comprehensive review

  2024cites this paper
• A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1–42 Peptide in the Brain and Leads to Alzheimer’s Disease-Relevant Cognitive Changes in a Mouse Model

  2024cites this paper
• Unpaired deep learning for pharmacokinetic parameter estimation from dynamic contrast-enhanced MRI without AIF measurements

  2024cites this paper
• Association of Plasma Claudin-5 with Age and Alzheimer Disease

  2024cites this paper